AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

TENOFOVIR

10 registrations across 3 African markets— 8 active

Markets with TENOFOVIR

Recent registrations

Brand / ProductMarketHolderStatusExpires
TENOFOVIR HETERO 300MG COMPRIME PELLICULE BOITE DE 30🇨🇮Côte d'IvoireHETERO LABS LIMITEDexpiredAug 2024
TENOVIR 300MG COMPRIME PELLICULE BOITE DE 30🇨🇮Côte d'IvoireSCILIFE PHARMA (PRIVATE) LIMITEDexpiredFeb 2024
Tenofovir Disoproxil fumarate tablet 300mg
Tablets
🇹🇿TanzaniaHetero Labs Limitedactive
VIREAD
comprimé / 245 mg
🇸🇳SenegalGILEAD SCIENCESactive
TENOFOVIR HETERO
comprimé / 300 mg
🇸🇳SenegalHETERO LABS LIMITEDactive
TENOFOVIR MATRIX
comprimé pelliculé / 300 mg
🇸🇳SenegalMATRIX LABORATORIES LIMITEDactive
Texavir
Tablet, coated
🇹🇿TanzaniaQUALITY CHEMICAL INDUSTRIES LIMITEDactive
TENOFOVIR HETERO
comprimé / 300 mg
🇸🇳SenegalHETERO LABS LIMITEDactive
TENOFOVIR ALAFENAMIDE HEMIFUMARATE
Tablets
🇹🇿TanzaniaHetero Labs Limitedactive
TENOFOVIR MACLEODS
comprimé / 245 mg
🇸🇳SenegalMACLEODSactive

TENOFOVIR in Africa — Regulatory Overview

TENOFOVIR is registered across 3 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Tanzania, Côte d'Ivoire. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 8 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.